Editors' ChoiceCancer Not just another Notch Yevgeniya NusinovichScience Translational Medicine, AAAS, Washington, DC 20005, USA See allHide authors and affiliations Science Signaling 01 Sep 2015:Vol. 8, Issue 392, pp. ec252DOI: 10.1126/scisignal.aad3208 Yevgeniya Nusinovich AAAS, Washington, DC 20005, USAFind this author on Google Scholar Find this author on PubMed Search for this author on this site Article Info & Metrics eLetters Article Information vol. 8 no. 392 ec252 DOI: https://doi.org/10.1126/scisignal.aad3208 Published By: Science Signaling Print ISSN: 1945-0877 Online ISSN: 1937-9145 History: . Copyright & Usage: Copyright © 2015, American Association for the Advancement of Science Author Information Yevgeniya NusinovichScience Translational Medicine, AAAS, Washington, DC 20005, USA Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: August 2015 to April 2021 AbstractFullPdf Aug 2015500 Sep 201580610 Oct 20153200 Nov 20151800 Dec 20152800 Jan 20161300 Feb 20161100 Mar 20162700 Apr 20162300 May 2016400 Jun 20161100 Jul 20161400 Aug 20161300 Sep 20161400 Oct 20162000 Nov 20161000 Dec 2016500 Jan 20171000 Feb 20173300 Mar 20171000 Apr 20171600 May 20172300 Jun 20171300 Jul 20171500 Aug 20172000 Sep 20171800 Oct 20171100 Nov 20171900 Dec 2017900 Jan 2018800 Feb 20181200 Mar 20181200 Apr 20182700 May 20182300 Jun 20181600 Jul 2018800 Aug 20181400 Sep 20181200 Oct 20181500 Nov 20181300 Dec 20181000 Jan 20191100 Feb 20191300 Mar 20191200 Apr 2019700 May 2019900 Jun 2019500 Jul 2019300 Aug 2019400 Sep 2019700 Oct 20191100 Nov 2019500 Dec 2019500 Jan 20201000 Feb 2020500 Mar 2020500 Apr 20201100 May 2020300 Jun 2020400 Jul 2020800 Aug 2020600 Sep 2020600 Oct 2020700 Nov 2020900 Dec 20201700 Jan 2021700 Feb 2021300 Mar 2021700 Apr 2021100 View Abstract
Not just another Notch By Yevgeniya Nusinovich Science Signaling01 Sep 2015 : ec252 Targeting DLL3 with an antibody-drug conjugate eliminates tumor-initiating cells in high-grade pulmonary neuroendocrine cancers.
Not just another Notch By Yevgeniya Nusinovich Science Signaling01 Sep 2015 : ec252 Targeting DLL3 with an antibody-drug conjugate eliminates tumor-initiating cells in high-grade pulmonary neuroendocrine cancers.